ArticleAcademic radiology2016

Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or Gefitinib.

Mizuki Nishino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.